Phage-Derived Endolysin: A Novel Therapy for Acute Graft-Versus-Host Disease (VIDEO)
Caption
Identification of bacteriophage-derived enzyme and its antibacterial activity can contribute to novel therapies that target biofilm-forming bacteria and help in the treatment against acute graft-versus-host disease.
Credit
Kosuke Fujimoto, Seiya Imoto, and Satoshi Uematsu from The University of Tokyo
Usage Restrictions
Do not reuse without permission.
License
Original content